How The Motley Fool’s view on $CARL changed

2026-10-17Bullish
“Motley Fool CEO Tom Gardner Reveals 8 Stocks He'd Buy Now”
CarlsMed is a small, risky 3D-printed spinal implant company; its founder's expertise and mission make it promising, it belongs in a diversified portfolio, and the investment could double over the next five years.

Carls Mead is a unique company; it is not a $20 billion or $400 billion company. This is a company whose subsequent sales amount to approximately $50 million .

This is a kind of creative project for someone who has a lot of experience in medical devices and products. His father had to undergo spinal surgery, so he asked his son: "Can you, with your experience, customize the surgery that I will undergo in any way?"

That was the impetus for the creation of CarlsMed, a company that 3D-prints spinal implants.